Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Cancer predisposition in mice deficient for the metastasis-associated Mts1(S100A4) gene

Abstract

Metastasis-promoting Mts1(S100A4) protein belongs to the S100 family of Ca2+-binding proteins. A mouse strain with a germ-line inactivation of the S100A4 gene was generated. The mice were viable and did not display developmental abnormalities in the postnatal period. However, an abnormal sex ratio was observed in the litters with the S100A4−/− genotype, raising the possibility of a certain level of embryonic lethality in this strain. In all, 10% of 10–14-month-old S100A4-null animals developed tumors. This is a characteristic feature of mouse strains with inactivated tumor suppressor genes. Spontaneous tumors of S100A4−/− mice were p53 positive. Recently, we have shown that S100A4 interacts with p53 tumor suppressor protein and induces apoptosis. We proposed that impairment of this interaction could affect the apoptosis-promoting function of p53 that is involved in its tumor suppressor activity. The frequency of apoptosis in the spleen of S100A4−/− animals after whole-body γ-irradiation was reduced compared to the wild-type animals. The same was true for the transcriptional activation of the p53 target genes – waf/p21/cip1 and bax. Taken together, these observations indicate that spontaneous tumors in S100A4−/− mice are a result of functional destabilization of p53 tumor suppressor gene.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Al-Haddad S, Zhang Z, Leygue E, Snell L, Huang A, Niu Y, Hiller-Hitchcock T, Hole K, Murphy LC and Watson PH . (1999). Am. J. Pathol., 155, 2057–2066.

  • Ambartsumian N, Klingelhofer J, Grigorian M, Christensen C, Kriajevska M, Tulchinsky E, Georgiev G, Berezin V, Bock E, Rygaard J, Cao R, Cao Y and Lukanidin E . (2001). Oncogene, 20, 4685–4695.

  • Ambartsumian N, Klingelhofer J, Grigorian M, Karlstrom O, Sidenius N, Georgiev G and Lukanidin E . (1998–99). Invas. Metast., 18, 96–104.

  • Ambartsumian NS, Grigorian MS, Larsen IF, Karlstrom O, Sidenius N, Rygaard J, Georgiev G and Lukanidin E . (1996). Oncogene, 13, 1621–1630.

  • Armstrong JF, Kaufman MH, Harrison DJ and Clarke AR . (1995). Curr. Biol., 5, 931–936.

  • Bian J and Sun Y . (1997). Mol. Cell. Biol., 17, 6330–6338.

  • Borresen-Dale AL . (2003). Hum. Mutat., 21, 292–300.

  • Bourdon JC, Deguin-Chambon V, Lelong JC, Dessen P, May P, Debuire B and May E . (1997). Oncogene, 14, 85–94.

  • Bouvard V, Zaitchouk T, Vacher M, Duthu A, Canivet M, Choisy-Rossi C, Nieruchalski M and May E . (2000). Oncogene, 9, 649–660.

  • Buzard GS . (1996). Mutat. Res., 365, 43–58.

  • Cazorla M, Hernandez L, Fernandez PL, Fabra A, Peinado MA, Dasenbrock C, Tillmann T, Kamino K, Campo E, Kohler M, Morawieltz G, Cardesa A, Tomatis L and Mohr U . (1998). Mol. Carcinogen., 21, 251–260.

  • Chen DS and Barraclough R . (1996). Biochem. Soc. Trans., 24, 352S.

  • Chen H, Fernig DG, Rudland PS, Sparks A, Wilkinson MC and Barraclough R . (2001). Biochem. Biophys. Res. Commun., 286, 1212–1217.

  • Christensen CR, Klingelhofer J, Tarabykina S, Hulgaard EF, Kramerov D and Lukanidin E . (1998). Cancer Res., 58, 1238–1244.

  • Cohn MA, Hjelmso I, Wu LC, Guldberg P, Lukanidin EM and Tulchinsky EM . (2001). Nucleic Acids Res., 29, 3335–3346.

  • Dameron KM, Volpert OV, Tainsky MA and Bouck N . (1994). Science, 265, 1582–1584.

  • Davies BR, O'Donnell M, Durkan GC, Rudland PS, Barraclough R, Neal DE and Mellon J . (2002). J. Pathol., 196, 292–299.

  • Davies M, Harris S, Rudland P and Barraclough R . (1995). DNA Cell. Biol., 14, 825–832.

  • Davies MP, Rudland PS, Robertson L, Parry EW, Jolicoeur P and Barraclough R . (1996). Oncogene, 13, 1631–1637.

  • Donato R . (2001). Int. J. Biochem. Cell. Biol., 33, 637–668.

  • Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS and Bradley A . (1992). Nature, 356, 215–221.

  • Du XJ, Cole TJ, Tenis N, Gao XM, Kontgen F, Kemp BE and Heierhorst J . (2002). Mol. Cell. Biol., 22, 2821–2829.

  • Duddy SK, Parker RF, Bleavins MR, Gough AW, Rowse PE, Gorospe S, Dethlof LA and de la Iglesia FA . (1999). Toxicol. Appl. Pharmacol., 156, 106–112.

  • Ebralidze A, Tulchinsky E, Grigorian M, Afanasyeva A, Senin V, Revazova E and Lukanidin E . (1989). Genes Dev., 3, 1086–1093.

  • El-Deiry WS . (1998). Semin. Cancer Biol., 8, 345–357.

  • Endo H, Takenaga K, Kanno T, Satoh H and Mori S . (2002). J. Biol. Chem., 277, 26396–26402.

  • Fei P, Bernhard EJ and El-Deiry WS . (2002). Cancer Res., 62, 7316–7327.

  • Feng G, Xu X, Youssef EM and Lotan R . (2001). Cancer Res., 61, 7999–8004.

  • Ford HL and Zain SB . (1995). Oncogene, 10, 1597–1605.

  • Greenblatt MS, Bennett WP, Hollstein M and Harris CC . (1994). Cancer Res., 54, 4855–4878.

  • Grigorian M, Andresen S, Tulchinsky E, Kriajevska M, Carlberg C, Kruse C, Cohn M, Ambartsumian N, Christensen A, Selivanova G and Lukanidin E . (2001). J. Biol. Chem., 276, 22699–22708.

  • Guerreiro Da Silva ID, Hu YF, Russo IH, Ao X, Salicioni AM, Yang X and Russo J . (2000). Int. J. Oncol., 16, 231–240.

  • Hakem R and Mak TW . (2001). Annu. Rev. Genet., 35, 209–241.

  • Hanahan D and Weinberg RA . (2000). Cell, 100, 57–70.

  • Heizmann CW, Fritz G and Schafer BW . (2002). Front. Biosci., 7, d1356–d1368.

  • Hobbs JA, May R, Tanousis K, McNeill E, Mathies M, Gebhardt C, Henderson R, Robinson MJ and Hogg N . (2003). Mol. Cell. Biol., 23, 2564–2567.

  • Hsieh H-L, Schäfer BW, Cox JA and Heizmann CW . (2002). J. Cell. Sci., 115, 3149–3158.

  • Iacopetta B . (2003). Hum. Mutat., 21, 271–276.

  • Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT and Weinberg RA . (1994). Curr. Biol., 4, 1–7.

  • Johnson DG . (2000). Mol. Carcinogen., 27, 151–157.

  • Klingelhofer J, Ambartsumian NS and Lukanidin EM . (1997). Dev. Dyn., 210, 87–95.

  • Komarova EA, Christov K, Faerman AI and Gudkov AV . (2000). Oncogene, 19, 3791–3798.

  • Kriajevska M, Fischer-Larsen M, Moertz E, Vorm O, Tulchinsky E, Grigorian M, Ambartsumian N and Lukanidin E . (2002). J. Biol. Chem., 277, 5229–5235.

  • Kriajevska MV, Cardenas MN, Grigorian MS, Ambartsumian NS, Georgiev GP and Lukanidin EM . (1994). J. Biol. Chem., 269, 19679–19682.

  • Kuperwasser C, Hurlbut GD, Kittrell FS, Dickinson ES, Laucirica R, Medina D, Naber SP and Jerry DJ . (2000). Am. J. Pathol., 157, 2151–2159.

  • Lukanidin EM and Georgiev GP . (1996). Curr. Top. Microbiol. Immunol., 213, 171–195.

  • Mandinova A, Atar D, Schafer BW, Spiess M, Aebi U and Heizmann CW . (1998). J. Cell. Sci., 111, 2043–2054.

  • Manitz MP, Horst B, Seeliger S, Strey A, Skryabin BV, Gunzer M, Frings W, Schonlau F, Roth J, Sorg C and Nacken W . (2003). Mol. Cell. Biol., 23, 1034–1043.

  • Mansouri A . (1998). Cell Biology: A Laboratory Handbook, 2nd edn, Vol. 3. Celis JE (ed). Academic Press: New York, pp. 478–486.

    Google Scholar 

  • Mashimo T, Watabe M, Hirota S, Hosobe S, Miura K, Tegtmeyer PJ, Rinker-Shaeffer CW and Watabe K . (1998). Proc. Natl. Acad. Sci. USA, 95, 11307–11311.

  • Mazzucchelli L . (2002). Am. J. Pathol., 160, 7–13.

  • Mercer WE, Shields MT, Lin D, Appella E and Ullrich SJ . (1991). Proc. Natl. Acad. Sci. USA, 88, 1958–1962.

  • Meuwissen R, Jonkers J and Berns A . (2001). Exp. Cell. Res., 264, 100–110.

  • Mombaerts P, Wang F, Dulac C, Chao SK, Nemes A, Mendelsohn M, Edmondson J and Axel R . (1996). Cell, 87, 675–686.

  • Novitskaya V, Grigorian M, Kriajevska M, Tarabykina S, Bronstein I, Berezin V, Bock E and Lukanidin E . (2000). J. Biol. Chem., 275, 41278–41286.

  • Passey RJ, Williams E, Lichanska AM, Wells C, Hu S, Geczy CL, Little MH and Hume DA . (1999). J. Immunol., 163, 2209–2216.

  • Pedrocchi M, Schafer BW, Mueller H, Eppenberger U and Heizmann CW . (1994). Int. J. Cancer, 57, 684–690.

  • Pelc P, Vanmuylder N, Lefranc F, Heizmann CW, Hassid S, Salmon I, Kiss R, Louryan S and Decaestecker C . (2003). Histopathology, 42, 387–394.

  • Platt-Higgins AM, Renshaw CA, West CR, Winstanley JH, De Silva Rudland S, Barraclough R and Rudland PS . (2000). Int. J. Cancer, 89, 198–208.

  • Ridinger K, Ilg EC, Niggli FK, Heizmann CW and Schafer BW . (1998). Biochim. Biophys. Acta, 1448, 254–263.

  • Rosty C, Ueki T, Argani P, Jansen M, Yeo CJ, Cameron JL, Hruban RH and Goggins M . (2002). Am. J. Pathol., 160, 45–50.

  • Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT and Jacks T . (1995). Nat. Genet., 10, 175–180.

  • Sauer B . (1993). Methods Enzymol., 225, 890–900.

  • Schafer BW, Fritschy JM, Murmann P, Troxler H, Durussel I, Heizmann CW and Cox JA . (2000). J. Biol. Chem., 275, 30623–30630.

  • Schuijer M and Berns EM . (2003). Hum. Mutat., 21, 285–291.

  • Staib F, Hussain SP, Hofseth LJ, Wang XW and Harris CC . (2003). Hum. Mutat., 21, 201–216.

  • Sun Y, Cheung JM, Martel-Pelletier J, Pelletier JP, Wenger L, Altman RD, Howell DS and Cheung HS . (2000). J. Biol. Chem., 275, 11327–11332.

  • Sun Y, Sun Y, Wenger L, Rutter JL, Brinckerhoff CE and Cheung HS . (1999). J. Biol. Chem., 274, 11535–11540.

  • Teratani T, Watanabe T, Yamahara K, Kumagai H, Ishikawa A, Arai K and Nozawa R . (2002). Biochem. Biophys. Res. Commun., 291, 623–627.

  • Turusov V and Mohr U (eds). (1994). Pathology of Tumors in Laboratory Animals, Vol.2—Tumors of the Mouse, 2nd edn. IARS Scientific Publications: Lyon.

    Google Scholar 

  • Vousden KH . (2002). Biochem. Biophys. Acta, 1602, 47–59.

  • Weterman MA, van Muijen GN, Bloemers HP and Ruiter DJ . (1993). Cancer Res., 53, 6061–6066.

  • Wu GS, Saftig P, Peters C and El-Deiry WS . (1998). Oncogene, 16, 2177–2183.

  • Xiong Z, O'Hanlon D, Becker LE, Roder J, MacDonald JF and Marks A . (2000). Exp. Cell. Res., 257, 281–289.

  • Yonemura Y, Endou Y, Kimura K, Fushida S, Bandou E, Taniguchi K, Kinoshita K, Ninomiya I, Sugiyama K, Heizmann CW, Schafer BW and Sasaki T . (2000). Clin. Cancer Res., 6, 4234–4242.

Download references

Acknowledgements

We thank Ingrid Fossar-Larsen, Birgitte Kaas, Dorrit Lützhøft and Sharif Mahsur for excellent technical assistance. We also thank Anne-Marie Hansen for the help in the preparation of the manuscript. This work was supported by grants from Danish Cancer Society, Danish Research Council and Dansk Kraeftforsknings Fond.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Noona Ambartsumian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

EL Naaman, C., Grum-Schwensen, B., Mansouri, A. et al. Cancer predisposition in mice deficient for the metastasis-associated Mts1(S100A4) gene. Oncogene 23, 3670–3680 (2004). https://doi.org/10.1038/sj.onc.1207420

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207420

Keywords

This article is cited by

Search

Quick links